Nov 7 (Reuters) - Cellmid Ltd CDY.AX :
* EUROPEAN PATENT OFFICE ISSUES INTENTION TO GRANT FOR MIDKINE N-DOMAIN ANTIBODY PATENT
* PATENT COVERING LYRAMID'S ANTIBODY RECOGNIZING N-DOMAIN OF MIDKINE GRANTED IN USA
* HAS RECENTLY FILED TWO NEW PROVISIONAL PATENT APPLICATIONS FOR LYRAMID'S N-DOMAIN ANTIBODIES